Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Technology can greatly enhance business profitability. Learn how to utilize it effectively for improved financial outcomes.
18,386 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
Struggling to price a fix up? This guide shows you how to estimate rehab costs from scratch, step by step, with clear...
Apple doubles down on returning capital to shareholders with a $100 billion buyback and a dividend hike, while rivals...
Morgan Stanley warns a disruption through the Strait of Hormuz could lift Brent to as high as $150 a barrel by summer...
Wednesday’s top analyst calls push trading as investors weigh inflation data, Fed policy, and AI-driven peers. AMD, J...
Nvidia is poised to deliver another strong earnings quarter, but history shows a big print doesn’t always move the st...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Renew (rnw) just released its 2026 earnings, signaling momentum in project execution and cash flow. This article brea...
A leading hedge fund shocks markets with a major pivot into AI infrastructure, prioritizing hardware, energy-ready da...
A legendary TV moment reveals a surprising truth about time and money. When a star says she never watched her own hit...
You're weighing two paths: paying down a rental mortgage or buying additional rental doors. This guide breaks down th...